Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Taiho Oncology
Sort By
Newest First
1 / 1
1 / 1
Oncology
NCCN Awarded $2 Million in Research Funding from Taiho Oncology to Study Trifluridine and Tipiracil in Various Cancers
National Comprehensive Cancer Network
PR-M10-18-NI-077
Oct 23, 2018
Oncology
Taiho Oncology Announces Positive Topline Results from Pivotal Phase 3 Trial of LONSURF® (trifluridine/tipiracil) in Metastatic Gastric Cancer
Taiho Oncology, Inc.
PR-M05-18-NI-045
May 11, 2018
Symposium
Taiho Oncology and Servier Present LONSURF® (trifluridine and tipiracil) Metastatic Colorectal Cancer (mCRC) Data at ASCO 2018 Gastrointestinal Cancers Symposium
Taiho Oncology, Inc.
PR-M01-18-NI-080
Jan 25, 2018
